Efficacy and safety of TACE combined with tyrosine kinase inhibitors and camrelizumab for unresectable hepatocellular carcinoma: A systematic review and meta‑analysis
Article in Oncology Letters (June 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Oncology Letters (June 2024)
Article in Frontiers in Immunology (May 2024)
Article in Medicine (May 2024)